Xiangjie Luo Selected Research

Drug Therapy (Chemotherapy)

12/2021	Arsenite-loaded albumin nanoparticles for targeted synergistic chemo-photothermal therapy of HCC.
1/2021	Hypoxia-Activated Prodrug Enabling Synchronous Chemotherapy and HIF-1α Downregulation for Tumor Treatment.
1/2021	Activatable Mitochondria-Targeting Organoarsenic Prodrugs for Bioenergetic Cancer Therapy.
1/2020	Recent advances of nanomedicines for liver cancer therapy.
5/2019	An extracellular pH-driven targeted multifunctional manganese arsenite delivery system for tumor imaging and therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiangjie Luo Research Topics

Disease

11	Neoplasms (Cancer) 12/2022 - 01/2018
2	Inflammation (Inflammations) 05/2024 - 01/2023
2	Liver Neoplasms (Liver Cancer) 04/2024 - 01/2020
1	Neuroblastoma 05/2024
1	Hepatocellular Carcinoma (Hepatoma) 04/2024
1	Epilepsy (Aura) 03/2024
1	Rheumatoid Arthritis 01/2023
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Pathologic Processes 12/2021
1	Acute Kidney Injury (Acute Renal Failure) 12/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Acute Promyelocytic Leukemia 05/2019
1	Carcinoma (Carcinomatosis) 12/2018

Drug/Important Bio-Agent (IBA)

4	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 10/2021
4	ProdrugsIBA 01/2022 - 01/2021
2	Therapeutic UsesIBA 01/2023 - 01/2022
2	Arsenic Trioxide (Trisenox)FDA Link 05/2019 - 12/2018
1	LipopolysaccharidesIBA 05/2024
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 04/2024
1	AcetyltransferasesIBA 04/2024
1	Fluorescent Dyes (Fluorescent Probes)IBA 04/2024
1	Superoxides (Superoxide)IBA 03/2024
1	Molecular Probes (Molecular Probe)IBA 03/2024
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2023
1	FluorineIBA 12/2022
1	N-azidoacetylmannosamineIBA 12/2022
1	Biomarkers (Surrogate Marker)IBA 11/2022
1	1- cyclohexyl- 2- (5H- imidazo(5,1- a)isoindol- 5- yl)ethanolIBA 01/2022
1	AntigensIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	CytokinesIBA 01/2022
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	IonsIBA 12/2021
1	VimentinIBA 12/2021
1	Oxygen (Dioxygen)IBA 12/2021
1	Reactive Nitrogen SpeciesIBA 12/2021
1	NitrogenIBA 12/2021
1	Photosensitizing Agents (Photosensitizers)IBA 10/2021
1	Singlet OxygenIBA 10/2021
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2021
1	CamptothecinIBA 10/2021
1	Mitochondrial DNA (mtDNA)IBA 01/2021
1	ManganeseIBA 05/2019
1	arseniteIBA 05/2019
1	Drug CombinationsIBA 12/2018
1	Cisplatin (Platino)FDA LinkGeneric 12/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2018
1	Contrast MediaIBA 01/2018
1	GadoliniumIBA 01/2018
1	AlbuminsIBA 01/2018
1	Human Serum Albumin FDA LinkGeneric 01/2018
1	Glycyrrhetinic Acid (Po 12)IBA 01/2018

Therapy/Procedure

6	Therapeutics 03/2024 - 01/2018
5	Drug Therapy (Chemotherapy) 12/2021 - 05/2019
1	Ligation 12/2022
1	Immunotherapy 01/2022
1	Precision Medicine 05/2019
1	Photothermal Therapy 01/2018
1	Lasers (Laser) 01/2018